May 21, 2026 · Form 4 insider transaction
Del Giudice Matthew Paul sold 25,000 shares of Telomir Pharmaceuticals, Inc., a transaction worth N/A. The trade was recorded as disposition to the issuer and disclosed on an SEC Form 4, filed 1 day after the transaction.
The reporting person agreed to cancellation of the option granted to him on 08/27/2024, in exchange for a new option having a lower exercise price.